David G
PRESIDENT AND CEO
Biotechnology
 CARDAX COMPANY
Haiti
Biography
Mr. Watumull has more than twenty years experience as a biotechnology industry executive, analyst, and investment banker. He is co-founder of Cardax and co-inventor of the Cardax technology. Previously, as CEO of Hawaii Biotech, he led efforts that resulted in more than $25 million in investor financing and $30 million in federal grant and contract funding. Hawaii Biotech’s dengue vaccine, which progressed significantly during his tenure from this funding, is undergoing late stage clinical development at Merck. He also started and led a West Nile virus vaccine program at Hawaii Biotech that achieved success in a human proof of concept study.
Research Interest
Mr. Watumull has more than twenty years experience as a biotechnology industry executive, analyst, and investment banker. He is co-founder of Cardax and co-inventor of the Cardax technology. Previously, as CEO of Hawaii Biotech, he led efforts that resulted in more than $25 million in investor financing and $30 million in federal grant and contract funding. Hawaii Biotech’s dengue vaccine, which progressed significantly during his tenure from this funding, is undergoing late stage clinical development at Merck. He also started and led a West Nile virus vaccine program at Hawaii Biotech that achieved success in a human proof of concept study.
